Abstract
Driven by rapid technical advances, color-coded Doppler ultrasonography is progressing fast. Early skepticism about the value of the technique has been replaced by growing enthusiasm, and Doppler color flow mapping is now accepted as a valuable aid to the investigation of peripheral arterial and venous disease. In the vast majority of routine investigations the technique has the potential to replace invasive arteriography and phlebography. Despite the ever-increasing sensitivity of ultrasound hardware, visualizing slow-flowing blood vessels in the deeper tissues and detecting flow signals that have been attenuated by overlying calcifications or pockets of bowel gas still poses severe problems. Indeed, the iliac region, the peripheral segments of the deep femoral arteries, the area around the adductor canal and the proximal calf, especially in obese patients, are frequently regarded as inaccessible to ultrasonography. Circulatory problems in these areas affect a certain number of the patients referred to a peripheral vascular disease clinic, so the intense interest in the development of an agent that enhances the Doppler signal from the arteries and veins of the leg is hardly surprising. If that enhancement proves clinically useful, and if it can be produced by a peripheral intravenous injection, it will offer several important advantages over X-ray arteriography. Gray-scale images from the peripheral circulation are too poor, even after enhancement, to give any useful information, and Doppler enhancement is the only effect that has any diagnostic value.
This chapter has been published in Advances in Echo-Enhancement 1997;1:30-42
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schlief R, Schürman R, Balzer T, et al. Saccharide based contrast agents. In: Advances in Echo Imaging Using Contrast Enhancement. Nanda N, Schlief R, editors. Dordrecht, Kluwer Academic;1993:58–71.
Progress in contrast echocardiography I and II. A series of presentations delivered at the 11th symposium on echo-cardiography, Rotterdam, June 21–22 1995. Adv Cardiac Echo-Contrast. 1995; 4: 82–94.
Muan B. A survey of the results from clinical trials of Infoson. Presented at the First European Symposium on Ultrasound Contrast Imaging, Rotterdam, Jan 25–26 1996.
Langholz J, Wanke M, Petry J et al. Echo-enhanced ultrasound imaging of leg arteries with Levovist (SH U 508 A) - multicenter clinical trial results. Angiology 1996;47(7), Part 2.
Langholz J, Schlief R, Schürmann R et al. Contrast enhancement in leg vessels. Clin Radiol 1996; 51 (Suppl. 1): 31–4.
Schlief R. Echo-enhanced Doppler imaging: the Levovist trial. Adv Echo-Enhancement 1996; 1: 2–3.
Langholz J, Heidrich H, Behrendt C et al. Ultrasonic contrast medium in the diagnosis of deep venous thrombosis? Phlebologie 1989; 89: 366–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Langholz, J.P. (1997). Ultrasound contrast agents in peripheral vascular disease. In: Nanda, N.C., Schlief, R., Goldberg, B.B. (eds) Advances in Echo Imaging Using Contrast Enhancement. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5704-9_35
Download citation
DOI: https://doi.org/10.1007/978-94-011-5704-9_35
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6405-7
Online ISBN: 978-94-011-5704-9
eBook Packages: Springer Book Archive